These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 8679305

  • 1. Delayed virus-specific CD8+ cytotoxic T lymphocyte activity in an HIV-infected individual with high CD4+ cell counts: correlations with various parameters of disease progression.
    Dalod M, Fiorentino S, Delamare C, Rouzioux C, Sicard D, Guillet JG, Gomard E.
    AIDS Res Hum Retroviruses; 1996 Apr 10; 12(6):497-506. PubMed ID: 8679305
    [Abstract] [Full Text] [Related]

  • 2. Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1.
    Bouscarat F, Levacher-Clergeot M, Dazza MC, Strauss KW, Girard PM, Ruggeri C, Sinet M.
    AIDS Res Hum Retroviruses; 1996 Jan 01; 12(1):17-24. PubMed ID: 8825614
    [Abstract] [Full Text] [Related]

  • 3. Human immunodeficiency virus type 1 replication, immune activation, and circulating cytotoxic T cells against uninfected CD4+ T cells.
    Kottilil S, Gamberg J, Bowmer I, Trahey J, Howley C, Gallant M, Grant M.
    J Clin Immunol; 2000 May 01; 20(3):175-86. PubMed ID: 10941825
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors.
    Betts MR, Krowka JF, Kepler TB, Davidian M, Christopherson C, Kwok S, Louie L, Eron J, Sheppard H, Frelinger JA.
    AIDS Res Hum Retroviruses; 1999 Sep 01; 15(13):1219-28. PubMed ID: 10480635
    [Abstract] [Full Text] [Related]

  • 7. Human CD28-CD8+ T cells contain greatly expanded functional virus-specific memory CTL clones.
    Weekes MP, Carmichael AJ, Wills MR, Mynard K, Sissons JG.
    J Immunol; 1999 Jun 15; 162(12):7569-77. PubMed ID: 10358214
    [Abstract] [Full Text] [Related]

  • 8. Factors related to loss of HIV-specific cytotoxic T lymphocyte activity.
    Gamberg J, Barrett L, Bowmer MI, Howley C, Grant M.
    AIDS; 2004 Mar 05; 18(4):597-604. PubMed ID: 15090764
    [Abstract] [Full Text] [Related]

  • 9. Activated peripheral CD8 lymphocytes express CD4 in vivo and are targets for infection by human immunodeficiency virus type 1.
    Imlach S, McBreen S, Shirafuji T, Leen C, Bell JE, Simmonds P.
    J Virol; 2001 Dec 05; 75(23):11555-64. PubMed ID: 11689637
    [Abstract] [Full Text] [Related]

  • 10. Longitudinal study of HIV-specific cytotoxic lymphocytes in HIV type 1-infected patients: relative balance between host immune response and the spread of HIV type 1 infection.
    Bariou C, Genetet N, Ruffault A, Michelet C, Cartier F, Genetet B.
    AIDS Res Hum Retroviruses; 1997 Oct 10; 13(15):1301-12. PubMed ID: 9339847
    [Abstract] [Full Text] [Related]

  • 11. CD25+ regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8+ T cells in vitro.
    Kinter AL, Horak R, Sion M, Riggin L, McNally J, Lin Y, Jackson R, O'shea A, Roby G, Kovacs C, Connors M, Migueles SA, Fauci AS.
    AIDS Res Hum Retroviruses; 2007 Mar 10; 23(3):438-50. PubMed ID: 17411377
    [Abstract] [Full Text] [Related]

  • 12. Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia.
    Zaunders JJ, Cunningham PH, Kelleher AD, Kaufmann GR, Jaramillo AB, Wright R, Smith D, Grey P, Vizzard J, Carr A, Cooper DA.
    J Infect Dis; 1999 Aug 10; 180(2):320-9. PubMed ID: 10395845
    [Abstract] [Full Text] [Related]

  • 13. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
    Kaiser P, Joos B, Niederöst B, Weber R, Günthard HF, Fischer M.
    J Virol; 2007 Sep 10; 81(18):9693-706. PubMed ID: 17609262
    [Abstract] [Full Text] [Related]

  • 14. Normalization of CD4+ cell numbers and reduced levels of memory CD8+ cells in blood and tonsillar tissue after highly active antiretroviral therapy in early HIV type-1 infection.
    Dyrhol-Riise AM, Voltersvik P, Røsok BI, Olofsson J, Asjö B.
    AIDS Res Hum Retroviruses; 2000 Feb 10; 16(3):191-201. PubMed ID: 10710207
    [Abstract] [Full Text] [Related]

  • 15. Effect of long-term infection with nef-defective attenuated HIV type 1 on CD4+ and CD8+ T lymphocytes: increased CD45RO+CD4+ T lymphocytes and limited activation of CD8+ T lymphocytes.
    Zaunders JJ, Geczy AF, Dyer WB, McIntyre LB, Cooley MA, Ashton LJ, Raynes-Greenow CH, Learmont J, Cooper DA, Sullivan JS.
    AIDS Res Hum Retroviruses; 1999 Nov 20; 15(17):1519-27. PubMed ID: 10580402
    [Abstract] [Full Text] [Related]

  • 16. Characteristics of HIV-1-specific CD8 T-cell responses and their role in loss of viremia in children chronically infected with HIV-1 undergoing highly active antiretroviral therapy.
    Zhang Z, Zhao QX, Fu JL, Yao JX, He Y, Jin L, Wang FS.
    Chin Med J (Engl); 2006 Dec 05; 119(23):1949-57. PubMed ID: 17199938
    [Abstract] [Full Text] [Related]

  • 17. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
    Villacres MC, Lacey SF, La Rosa C, Krishnan R, Auge C, Longmate J, Zaia JA, Leedom JM, Diamond DJ.
    J Infect Dis; 2001 Aug 01; 184(3):256-67. PubMed ID: 11443550
    [Abstract] [Full Text] [Related]

  • 18. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection.
    Musey L, Hughes J, Schacker T, Shea T, Corey L, McElrath MJ.
    N Engl J Med; 1997 Oct 30; 337(18):1267-74. PubMed ID: 9345075
    [Abstract] [Full Text] [Related]

  • 19. Clinical outcome of HIV viraemic controllers and noncontrollers with normal CD4 counts is exclusively determined by antigen-specific CD8+ T-cell-mediated HIV suppression.
    Tansiri Y, Rowland-Jones SL, Ananworanich J, Hansasuta P.
    PLoS One; 2015 Oct 30; 10(3):e0118871. PubMed ID: 25764310
    [Abstract] [Full Text] [Related]

  • 20. Effector HIV-specific cytotoxic T-lymphocyte activity in long-term nonprogressors: associations with viral replication and progression.
    Keoshkerian E, Ashton LJ, Smith DG, Ziegler JB, Kaldor JM, Cooper DA, Stewart GJ, Ffrench RA.
    J Med Virol; 2003 Dec 30; 71(4):483-91. PubMed ID: 14556259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.